• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Med Res Opin . Prevalence of health conditions associated with higher risk for severe respiratory syncytial virus, influenza or COVID-19

tetano

Editor, Senior Moderator
Curr Med Res Opin


. 2025 Jul 21:1-13.
doi: 10.1080/03007995.2025.2535456. Online ahead of print. Prevalence of health conditions associated with higher risk for severe respiratory syncytial virus, influenza or COVID-19

Abby Hitchens[SUP] 1 [/SUP], Sean D Candrilli[SUP] 1 [/SUP], Justin Carrico[SUP] 1 [/SUP], Katherine A Hicks[SUP] 1 [/SUP], Eleanor Wilson[SUP] 2 [/SUP], Darshan Mehta[SUP] 2 [/SUP], Catherine A Panozzo[SUP] 2 [/SUP], Parinaz Ghaswalla[SUP] 2 [/SUP]



Affiliations
Abstract

Objective: Respiratory syncytial virus (RSV), influenza virus, and SARS-CoV-2 cause significant morbidity and mortality. Understanding prevalences of underlying conditions associated with higher risk for severe RSV, influenza, or COVID-19, and demographic trends in multi-morbidity prevalence, may help inform effective interventional strategies against these respiratory infections in high-risk populations.
Methods: This study analyzed data from the National Health and Nutrition Examination Survey (NHANES) database (2017-2018) from a representative sample of US adults (≥20 years).
Results: Of 239 million surveyed adults, 44.5% had ≥1 underlying condition associated with higher risk of severe RSV, influenza, or COVID-19; this proportion increased to 72.2% of adults if 2 additional underlying conditions were also considered (hypertension and smoking; both associated risk factors for severe COVID-19). Among older adults (≥60 years), the majority had ≥1 underlying condition associated with higher risk for severe RSV, influenza, or COVID-19. Across different racial/ethnic groups, overall prevalence of ≥2 conditions was highest among individuals of Other Race (including multiracial) at 19.5%, followed by non-Hispanic Black (18.9%), non-Hispanic White (18.5%), Mexican-American/Other Hispanic (10.3%), and non-Hispanic Asian individuals (7.7%). Notably, non-Hispanic Black individuals had a higher prevalence of ≥1 underlying condition compared with other race/ethnicity groups across all age-groups <75 years.
Conclusions: These findings indicate increased prevalence of underlying health conditions associated with higher risk of severe RSV, influenza, or COVID-19 among older adults (≥60 years) and disproportionate prevalence among younger non-Hispanic Black individuals. Understanding racial and ethnic disparities in multimorbidity prevalence of underlying conditions can inform public health interventions that target these respiratory viruses.

Keywords: COVID-19; adult; comorbidity; ethnicity; influenza; race factors; respiratory syncytial virus.

 
Back
Top Bottom